HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia

References 

1. Abdala N, Stephens PC, Griffith BR, Heimer R. Survival of human immunodeficienty virus type 1 in syringes. Journal of the Aquired Immune Deficiency Syndromes and Human Retrovirology. 1999;20:73–80
2. Alcabes P, Beniowski M, Grund JP. Needle and syringe exchange in Poland and the Former Soviet Union: a new approach to community-impact studies. Journal of Drug Issues. 1999;29(4):861–880
3. Baron Edmond de Rothschild Chemical Dependency Institute Henman A, Titus S, Perlis T. Evaluation of syringe exchange programmes in Central and Eastern Europe. New York: Beth Israel Medical Center; 2001;
4. Baron Edmond de Rothschild Chemical Dependency Institute Perlis TST, Bodrova V, Zemlianova . Evaluation of syringe exchange programmes in Russia. New York: Beth Israel Medical Center; 2001;
5. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000;14:605–611
   • MEDLINE
   • CrossRef
6. Bobkov A, Kazennovam E, Khaninam T, Bobkovam M, Selimovam L, Kravchenkom A, et al. An HIV 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: study of the new local outbreaks in Moscow and Irkutsk. AIDS Research and Human Retroviruses. 2001;17:257–261
   • MEDLINE
   • CrossRef
7. Burger EJJ, Field MG, Twigg JL. From assurance to insurance in Russia health care: the problematic transition. America Journal of Public Health. 1998;88(5):755–758
8. Dehne KL, Khodakevich L, Hamers FF, Schwartlander B. The HIV/AIDS epidemic in Eastern Europe: recent patterns and trends and their implications for policy-making. AIDS. 1999;13:741–749
   • MEDLINE
   • CrossRef
9. Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association. 1995;274(15):1226–1231
10. Des Jarlais DC, Paone D, Milliken J, Turner C, Miller H, Gribble J, et al. Audio-computer interviewing to measure HIV-risk behaviour among injecting drug users: a quasi-randomised trial. The Lancet. 1999;353:1657–1661
11. Des Jarlais DC, Friedmann P, Hagan H, Friedman SR. The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. American Journal of Public Health. 1996;86(12):1780–1785
    • MEDLINE
    • CrossRef
12. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health. 2001;91(1):42–46
    • MEDLINE
13. Jose B, Friedman SR, Curtis R, Grund J-PC, Goldstein MF, Ward TP, et al. Syringe-mediated drug-sharing (backloading): A new risk factor for HIV among injecting drug users. AIDS. 1993;7:1653–1660
    • MEDLINE
    • CrossRef
14. Kobyshcha I. The determinants of the spread of HIV among injection drug addicts in Ukraine. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii. 1999;1:34–36
15. National Institutes of Health, US (1997). Interventions to Prevent HIV Risk Behaviors (Consensus Statement 104): National Institutes of Health.
16. Rhodes T, Ball A, Stimson GV, Kobyshcha Y, Fitch C, Pokrovsky V, et al. HIV infection associated with drug injecting in the Newly Independent States, eastern Europe: the social and economic contexts of epidemics. Addiction. 1999;94(9):1323–1336
    • MEDLINE
    • CrossRef
17. Samuels JF, Vlahov D, Anthony JC, Solomon L, Celentano DD. The practice of ‘frontloading’ among intravenous drug users: association with HIV-antibody. AIDS. 1991;5:343
    • MEDLINE
18. Shcherbinskaia AM, Kobyshcha IV, Kruglov IV, Chentsova NP, Bochkova LV, Maksimenok EV, et al. The epidemic situation in relation to HIV infection in Ukraine (1987–1997). Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii. 1999;1:26–29
19. Shkolnikov V, McKee M, Leon DA. Changes in life expectancy in Russia in the mid-1990s. The Lancet. 2001;357:917–921
20. Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS. 1996;10:311–317
    • MEDLINE
    • CrossRef
21. Stone R. Stress: the invisible hand in Eastern Europe's death rates. Science. 2000;288:1732–1733
    • MEDLINE
    • CrossRef
22. Thomsen PB. East Europe needs help to stop AIDS explosion—UN. Reuters; 2000;
23. van Ameijden EJ, van den Hoek JA, van Haastrecht HJ, Coutinho R. The harm reduction approach and risk factors for HIV seroconversion in injecting drug users, Amsterdam. American Journal of Epidemiology. 1992;136:236–243
    • MEDLINE
24. Verevochkin SV, Dyatlov RV, Gagarina SY, Olshansky AY, Pankova GY, Yakovets RA, et al. Detection of early HIV infection in HIV-seropositive patients registered during screening performed in Moscow in 1998. Russian Journal HIV/AIDS Related Problems. 1999;3:60–64
25. World Health Organization (2000). WHO Report on Global Surveillance of Epidemic-Prone Infectious Diseases: World Health Organization.